Correlation Between Apellis Pharmaceuticals and Atreca
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Atreca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Atreca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Atreca Inc, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Atreca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Atreca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Atreca.
Diversification Opportunities for Apellis Pharmaceuticals and Atreca
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Apellis and Atreca is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Atreca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atreca Inc and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Atreca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atreca Inc has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Atreca go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Atreca
If you would invest (100.00) in Atreca Inc on November 9, 2024 and sell it today you would earn a total of 100.00 from holding Atreca Inc or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Atreca Inc
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Atreca Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Apellis Pharmaceuticals and Atreca Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Atreca
The main advantage of trading using opposite Apellis Pharmaceuticals and Atreca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Atreca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will offset losses from the drop in Atreca's long position.| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
| Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |